Stephen Morton
12Patents
3h-index
9Co-inventors
53Inventor score
Filing activity: Oct 10, 1995 → Dec 14, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5646863A | Method and apparatus for detecting and classifying contaminants in water | Chemistry; Metallurgy | 74 | Expired |
| US10583083B1 | ROS-responsive multilamellar liposomal vesicles for targeting inflammatory macrophages | Emerging Cross-Sectional Technologies | 3 | Active |
| US10517823B1 | ROS—responsive liposomes for specific targeting | Emerging Cross-Sectional Technologies | 3 | Active |
| US11179335B1 | ROS-responsive liposomes for specific targeting | Emerging Cross-Sectional Technologies | 1 | Active |
| US10492709B2 | Magnetic probes for in vivo capture and detection of extracellular vesicles | Performing Operations; Transporting | 1 | Active |
| US10842746B1 | Bi-directionally crosslinked liposomes and method of making same | Human Necessities | 0 | Active |
| US11318097B1 | ROS-responsive multilamellar liposomal vesicles for targeting inflammatory macrophages | Emerging Cross-Sectional Technologies | 0 | Active |
| US12350369B2 | Serial filtration to generate small cholesterol-containing liposomes | Performing Operations; Transporting | 0 | Active |
| US11246832B2 | Serial filtration to generate small cholesterol-containing liposomes | Performing Operations; Transporting | 0 | Active |
| US10751284B1 | Targeted therapy to deplete tumor-associated macrophages (TAMs) | Chemistry; Metallurgy | 0 | Active |
| US10835619B1 | Targeted therapy to repolarize tumor-associated macrophages (TAMs) | Human Necessities | 0 | Active |
| US12102715B1 | ROS-responsive liposomes for specific targeting | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.